Free Trial

Intelligent Bio Solutions (INBS) Competitors

Intelligent Bio Solutions logo
$1.61 -0.29 (-15.26%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.64 +0.03 (+2.17%)
As of 07/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INBS vs. SURG, EDAP, QTI, ECOR, APT, INO, MLSS, DXR, TMDIF, and NMTC

Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include SurgePays (SURG), Edap Tms (EDAP), QT Imaging (QTI), electroCore (ECOR), Alpha Pro Tech (APT), Inovio Pharmaceuticals (INO), Milestone Scientific (MLSS), Daxor (DXR), Titan Medical (TMDIF), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry.

Intelligent Bio Solutions vs. Its Competitors

SurgePays (NASDAQ:SURG) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

SurgePays has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.6, indicating that its stock price is 360% more volatile than the S&P 500.

Intelligent Bio Solutions has lower revenue, but higher earnings than SurgePays.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SurgePays$60.88M0.99-$45.73M-$2.79-1.05
Intelligent Bio Solutions$3.11M3.58-$10.16MN/AN/A

6.9% of SurgePays shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 30.5% of SurgePays shares are held by insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, SurgePays and SurgePays both had 4 articles in the media. Intelligent Bio Solutions' average media sentiment score of 0.84 beat SurgePays' score of 0.76 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SurgePays
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Intelligent Bio Solutions
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SurgePays currently has a consensus target price of $9.00, suggesting a potential upside of 206.12%. Given SurgePays' stronger consensus rating and higher possible upside, equities analysts plainly believe SurgePays is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SurgePays
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Intelligent Bio Solutions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

SurgePays has a net margin of -136.37% compared to Intelligent Bio Solutions' net margin of -319.85%. Intelligent Bio Solutions' return on equity of -176.55% beat SurgePays' return on equity.

Company Net Margins Return on Equity Return on Assets
SurgePays-136.37% -206.01% -153.67%
Intelligent Bio Solutions -319.85%-176.55%-93.89%

Summary

Intelligent Bio Solutions beats SurgePays on 7 of the 13 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INBS vs. The Competition

MetricIntelligent Bio SolutionsMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$13.13M$7.30B$5.70B$9.50B
Dividend YieldN/A2.84%4.60%4.01%
P/E RatioN/A25.2828.1020.05
Price / Sales3.5842.19429.3789.38
Price / CashN/A26.7436.2258.56
Price / Book0.689.718.665.87
Net Income-$10.16M$239.96M$3.25B$258.55M
7 Day Performance-25.12%2.92%4.22%3.73%
1 Month Performance-4.73%4.88%10.51%11.75%
1 Year Performance7.33%15.47%34.40%18.03%

Intelligent Bio Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INBS
Intelligent Bio Solutions
1.0373 of 5 stars
$1.61
-15.3%
N/A+14.2%$13.13M$3.11M0.0010Positive News
Gap Up
SURG
SurgePays
3.2901 of 5 stars
$2.96
+1.7%
$9.00
+204.1%
-2.0%$59.40M$60.88M0.0040
EDAP
Edap Tms
3.0714 of 5 stars
$1.51
-0.7%
$8.50
+462.9%
-70.1%$56.84M$69.18M-2.44230
QTI
QT Imaging
N/A$2.08
+2.5%
N/A+194.2%$56.44M$4.00M0.00N/A
ECOR
electroCore
3.2618 of 5 stars
$7.10
-2.3%
$25.50
+259.2%
+29.2%$54.28M$25.18M-4.5550Positive News
APT
Alpha Pro Tech
1.124 of 5 stars
$4.74
-0.2%
N/A-19.0%$51.50M$58.18M12.81120
INO
Inovio Pharmaceuticals
3.9039 of 5 stars
$1.42
+2.2%
$8.80
+519.7%
-86.6%$50.98M$220K-0.45320High Trading Volume
MLSS
Milestone Scientific
2.7774 of 5 stars
$0.63
+1.9%
$1.25
+98.4%
-40.5%$49.44M$8.61M-9.0030Negative News
DXR
Daxor
3.9797 of 5 stars
$9.18
+2.0%
$25.00
+172.3%
+12.0%$43.53MN/A0.0037
TMDIF
Titan Medical
N/A$0.38
+2.8%
N/A+926.0%$43.37M$17.63M-0.3050Gap Down
NMTC
NeuroOne Medical Technologies
2.7449 of 5 stars
$0.90
+5.5%
$1.45
+61.1%
+10.8%$42.50M$3.45M-4.0920High Trading Volume

Related Companies and Tools


This page (NASDAQ:INBS) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners